SCI & TECH● LOWAug 14 · Aug 14, 2026, 12:28 AM
CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission
Seeking Alpha Tech
CapsoVision expects FDA clearance for its AI Highlights technology by the end of Q3 and plans to submit CapsoCam Colon for approval in Q4. This indicates progress in the development and regulatory pathway for new medical imaging technologies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH19m agoThe Machine StaffWar on the RocksSCI & TECH51m agoA giant 1,680-ton tunneling machine began drilling in New York: it will build a $16 billion railway tunnel to connect it with New JerseyClarínSCI & TECH57m agoCoreWeave expands AI computing capacity in Denmark; adds network locations across Asia Pacific, Middle EastSeeking Alpha TechSCI & TECH1h agoScientists uncover new clues to the actual night sky behind Van Gogh’s The Starry NightEuroNews [en]